Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2006-04-01
סדרה:	AIDS Research and Therapy
גישה מקוונת:	http://www.aidsrestherapy.com/content/3/1/11
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!